IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION. Halvorsen LV, Gognstad S, Soraas CL, Agnes C, et al. J Hypertens 2022;40.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Halvorsen LV, Gognstad S, Soraas CL, Agnes C, et al. IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION. J Hypertens 2022;40.
PMID: 36027460